Ensign Peak Advisors »

Tenax Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.6M 177k 14.55

More positions owned by Ensign Peak Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Applied Materials (AMAT)

View all positions for Ensign Peak Advisors

Top funds holding Tenax Therapeutics

FMR
T. Rowe Price Associates
Vivo Capital
Henderson Group
BlackRock
Perceptive Advisors
Ikarian Capital
Vanguard Capital Management
Citadel Advisors
Millennium Management
Candriam Luxembourg S.C.A.
Caption Management
Rtw Investments
Stonepine Capital Management
Geode Capital Management

View all funds holding Tenax Therapeutics